rosiglitazone has been researched along with gw 409544 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henke, BR | 1 |
| Chen, W; Fan, S; Li, S; Wang, L; Xie, Y; Xu, C; Zhong, W; Zhou, X | 1 |
| Dou, XZ; Duerfeldt, AS; Ma, JX; Nath, D; Shin, Y | 1 |
| Kaya, T; Sheu, SH; Vajda, S; Waxman, DJ | 1 |
| Al Sharif, M; Alov, P; Diukendjieva, A; Pajeva, I; Tsakovska, I; Vitcheva, V | 1 |
1 review(s) available for rosiglitazone and gw 409544
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
4 other study(ies) available for rosiglitazone and gw 409544
| Article | Year |
|---|---|
(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Lipids; Mice; PPAR alpha; PPAR gamma; Propionates | 2010 |
Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARĪ± selective agonists: New leads for oculovascular conditions.
Topics: Dose-Response Relationship, Drug; Eye Diseases; Humans; Ligands; Models, Molecular; Molecular Structure; PPAR alpha; Quinolines; Structure-Activity Relationship; Vascular Diseases | 2018 |
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
Topics: Alkanesulfonates; Binding Sites; Cinnamates; Computational Biology; Humans; Ligands; Oxazines; Oxazoles; Phenylpropionates; PPAR gamma; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Rosiglitazone; Solvents; Thiazoles; Thiazolidinediones; Thiazolidines; Tyrosine | 2005 |
Molecular Modeling Approach to Study the PPARĪ³-Ligand Interactions.
Topics: Humans; Hypoglycemic Agents; Ligands; Molecular Docking Simulation; Oxazoles; PPAR gamma; Protein Conformation; Quantitative Structure-Activity Relationship; Rosiglitazone; Tyrosine | 2019 |